Cleveland Clinic Enters ‘Long-term Strategic Alliance’ with Theranos Inc.

Cleveland Clinic and Theranos, a Palo Alto diagnostic company valued at more the $9 billion, have entered into a long-term strategic alliance. Theranos is known for its low cost blood tests that require only a few drops of blood.

Read More  >